UCB stock down as FDA asks for more Cimzia data
UCB has suffered a major blow with the news that US regulators have asked for more safety data on the Belgian drugmaker’s anti-tumour necrosis factor agent Cimzia as a treatment for rheumatoid arthritis
Viagra may be effective in preventing heart failure
Viagra, Pfizer's erectile dysfunction blockbuster, also has the potential to treat and prevent heart failure, US researchers have claimed
Endo to buy Indevus in deal worth up to $637 million
The year is less than a week old and the drugs sector’s first merger has been announced – Endo Pharmaceutical is to acquire Indevus
|
 |
MedImmune files LAIV nasal flu vaccine in Europe
AstraZeneca’s MedImmune unit is looking to get approval in Europe for the intranasal influenza vaccine which is sold in the USA as FluMist.
2007 saw US Rx drug spending’s lowest rise in over 40 years, says govt
US health care spending grew 6.1% in 2002 to $2.2 trillion, or $7,421 per capita, the slowest rate of rise since 1998, the government reports today. Over half of this slowdown was due to the year’s 4.9% growth in prescription drug spending, which is a sharp tumble from 8.6% in 2006 and the smallest rise in over 40 years.
PPD acquires Merck vaccine testing laboratory
US-based contract research organisation PPD has acquired a 130,000 sq ft vaccine testing laboratory and related equipment in Wayne, Pennsylvania as part of a collaborative agreement with Merck & Co.
|